Name: Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis (Video) | JoVE Journal
Uploaded: 2020-01-30T16:00:00.000+00:00
Duration: 10 min 35 s
Description: Learn markerless gene deletion in Chlamydia trachomatis using floxed cassette allelic exchange mutagenesis. This precise method enables targeted genetic manipulation without polar effects on downstream genes.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by Public Health Service grants from the National Institute of Health, NIAID (grants A1065530 and Al124649), to K.A. Fields.

1. Design and Assembly of pSUmC-4.0 with Homology Arms Specific to the Gene of Interest
<ol>
	<li>Identify ~3 kb regions directly upstream and downstream of the gene targeted for deletion to serve as the 5&#39; and 3&#39; homology arms for homologous recombination (Figure 1).</li>
	<li>Design PCR primers to 1) amplify the 3 kb 5&#39; homology arm from chlamydial genomic DNA and 2) contain a 15&#8211;30 bp overhang specific to pSUmC-4.0 when digested at the Sall restriction enzyme site. Ensure that the primer regions overlapping with pSUmC-4.0 have melting temperatures of 55 &#176;C and that hairpin melting temperatures for the entire primer are &#60;35 &#176;C.</li>
	<li>Design PCR primers to 1) amplify the 3 kb 3&#39; homology arm from chlamydial genomic DNA and 2) contain a 15&#8211;30 bp overhang specific to pSUmC-4.0 when digested at the SbfI restriction enzyme site. Ensure that the primer regions overlapping with pSUmC-4.0 have melting temperatures of 55 &#176;C and that hairpin melting temperatures for the entire primer are &#60;35 &#176;C.</li>
	<li>Design PCR screening primers that will amplify the insertion of each homology arm into the pSUmC-4.0 vector after a DNA assembly reaction16. Design these primers to anneal ~500 bp outside the restriction sites to allow easy visualization of a PCR product even if the insertion was unsuccessful (Figure 1).</li>
	<li>Amplify the 3 kb 5&#39; and 3&#39; homology arms from freshly extracted chlamydial genomic DNA by PCR in one to two reactions to yield enough fragment for later DNA assembly. Follow the DNA polymerase manufacturer&#39;s protocol for specific reaction set-up and cycling conditions.</li>
	<li>Verify that both PCR products are the correct size and that the reactions do not contain any contaminating bands. Run 5 &#956;L of each PCR reaction on a 1% DNA agarose gel.</li>
	<li>Purify and concentrate the PCR fragments by phenol/chloroform extraction and ethanol precipitation.
	<ol>
		<li>Pool all 3&#39; PCR reactions together in a 1.5 mL tube and bring to a final volume of 200 &#181;L with nuclease-free H2O. Repeat this process for the 5&#39; PCR reactions.</li>
		<li>Add 200 &#181;L of phenol to each tube and vortex for 30&#8211;60 s. Spin each tube in a microcentrifuge at &#62;21,000 x g for 20 min at room temperature (RT).</li>
		<li>Transfer the aqueous phase top layer of each tube into a new 1.5 mL tube, add one-tenth the volume of 3 M sodium acetate to each tube, then flick to mix.</li>
		<li>Add 3 volumes of 100% ethanol to each tube and flick to mix. Incubate both tubes at -80 &#176;C for 20 min.</li>
		<li>Pellet the DNA by spinning each tube at &#62;21,000 x g for 5 min at RT. Discard the supernatant.</li>
		<li>Wash the DNA pellet with 100 &#181;L of 70 % ethanol. Spin each tube at &#62;21,000 x g for 5 min at RT. Discard the supernatant.</li>
		<li>Wash the DNA pellet again with 100 &#181;L of 100% ethanol. Spin each tube at &#62;21,000 for 5 min at RT. Discard the supernatant.</li>
		<li>Let the pellet fully air-dry, then gently resuspend the DNA in 12 &#181;L of nuclease-free H2O by flicking to mix.</li>
	</ol>
	</li>
	<li>Digest 500 ng of pSUmC-4.0 vector in a 20 &#181;L reaction with 1 unit of Sall and 1 unit of SbfI according to the manufacture&#39;s protocol. Incubate the reaction for approximately 3 h or overnight to ensure complete digestion of the vector.</li>
	<li>Purify and concentrate the digested backbone by phenol/chloroform extraction and ethanol precipitation as described earlier (step 1.7.1&#8211;1.7.9).</li>
	<li>Combine the digested pSUmC-4.0 vector and both the 5&#39; and 3&#39; homology arm PCR products together at a ratio of 0.01 pmol pSUmC-4.0 to 0.09 pmol each homology arm. Assemble the fragments in a DNA assembly reaction according to the manufacture&#39;s protocol.</li>
	<li>Transform 50 &#181;L of electrocompetent E. coli with 1 &#181;L of the DNA assembly reaction. Plate the transformed E. coli onto LB agar plates containing 100 &#181;g/mL spectinomycin by spreading 150 &#181;L per plate. Incubate the plates at 37 &#176;C overnight.</li>
	<li>The next day, screen colonies for green and red fluorescence using an epifluorescence inverted microscope. A total of 5&#8211;30 colonies per agar plate is expected.</li>
	<li>Pick 5&#8211;10 colonies to inoculate 4 mL of LB broth supplemented with 100 &#181;g/mL spectinomycin. Incubate cultures at 37 &#176;C overnight with shaking at 250 rpm.</li>
	<li>Using the overnight E. coli cultures, perform small-scale DNA purification. Elute the DNA with 50 &#181;L of nuclease-free H2O.</li>
	<li>Confirm the insertion of each homology arm into the pSUmC-4.0 vector using the PCR screening primers (designed in step 1.4) to amplify each insertion. If DNA assembly is successful, a ~4 kb PCR product should be observed in a 1% DNA agarose gel for both the 5&#39; and 3&#39; arm regions. A ~1 kb PCR product indicates a lack of insertion. 
	NOTE: If the insertion of the homology arms is unsuccessful in a dual fragment assembly reaction, perform two assembly reactions to insert the 5&#39; arm then 3&#39; arm, individually. Digest the vector with only Sall before assembling with the 5&#39; arm, then digest the vector with SbfI to assemble the 3&#39; arm.</li>
	<li>Transform dam-/dcm- competent E. coli with 200 ng of pSUmc-4.0 assembled with both homology arms. Plate the transformed bacteria onto LB agar plates containing 100 &#181;g/mL spectinomycin by spreading 25 &#181;L per plate. Incubate the plates at 37 &#176;C overnight. A total of 20&#8211;200 colonies are expected.</li>
	<li>Screen the plates for red and green fluorescent colonies as described in step 1.13.</li>
	<li>Set up a culture for a large-scale DNA purification by inoculating 100 mL of LB broth containing 100 &#181;g/mL spectinomycin with red and green colonies. Incubate the culture at 37 &#176;C overnight with shaking at 250 rpm.</li>
	<li>Harvest the culture and purify the DNA using a large-scale DNA purification.
	<ol>
		<li>Resuspend the purified plasmid DNA in 100 &#181;L of NF-H2O. A total DNA yield of at least 2 &#181;g/&#181;L is ideal for C. trachomatis transformation.</li>
		<li>Sequence the 5&#39; and 3&#39; homology arm regions to ensure correct assembly into pSUmC-4.0 before transforming C. trachomatis.</li>
	</ol>
	</li>
</ol>
2. Transformation of C. trachomatis with pSUmC 4.0 + Homology Arms for Gene Deletion by Allelic Exchange
<ol>
	<li>Seed McCoy cells, mouse fibroblasts standardly used for cultivating Chlamydia, into two 6 well plates (1 x 106 cells/well) with growth media #1. Incubate the plates at 37 &#176;C with 5% CO2 until the monolayer is confluent (approximately 24 h).</li>
	<li>In a 1.5 mL tube, add a volume of C. trachomatis WT serovar L2 elementary bodies (EBs) that is sufficient to infect 12 wells of a 6 well plate at an MOI of 2. Pellet the EBs at &#62;20,000 x g for 30 min, then discard the supernatant.</li>
	<li>Initiate chlamydial transformation by gently resuspending the EBs in 600 &#181;L of CaCl2 buffer, and then add 24 &#181;g of pSUmC-4.0 + homology arms to the tube. Gently mix the solution by flicking. Incubate the tube at RTfor 30 min and flick to mix every 10 min.</li>
	<li>Add the transformation solution to 24 mL of Hanks&#39; balanced salt solution (HBSS) and mix by gently pipetting. Transfer 2 mL of the inoculum to each well of confluent McCoy cells in the 6 well plates and infect by centrifugation at 900 x g for 1 h at 20 &#176;C.</li>
	<li>Remove the inoculum and replace with 2 mL/well RPMI growth media #2. Incubate the plates at 37 &#176;C with 5% CO2.</li>
	<li>After a minimum of 7 h, but no more than 12 h, replace the media with 2 mL/well of selection media #1. Continue the incubation at 37 &#176;C for 48 h from the time of infection.</li>
	<li>Harvest and passage the bacteria onto a fresh monolayer of McCoy cells.
	<ol>
		<li>Using a cell scraper, gently scrape the McCoy monolayer to lift the cells into the media. Transfer the material from each well into a 2 mL tube. Pellet the cell material at &#62;20,000 x g in a microcentrifuge for 30 min at 4 &#176;C.</li>
		<li>Remove and discard the supernatant. Resuspend the cell pellet in 1 mL of HBSS by gently pipetting.</li>
		<li>Pellet the cell debris at 200 x g for 5 min at 4 &#176;C. Transfer the supernatant onto a fresh well of confluent McCoy cells. Add an additional 1 mL of HBSS to each well for a total volume of 2 mL/well.</li>
		<li>Infect by centrifugation at 900 x g for 1 h at 20 &#176;C. Replace the inoculum with selection media #1 immediately following infection.</li>
	</ol>
	</li>
	<li>Continue passaging the bacteria onto a fresh monolayer of McCoy cells (section 2.7) every 48 h for three or more passages until red and green inclusions are detected using an epifluorescence inverted microscope 24 h post-infection (24 hpi).</li>
	<li>Once red and green inclusions are detected, continue passaging the monolayer (section 2.7) using selection media #2.</li>
	<li>Continue passaging the monolayer until green-only inclusions are detected 24 hpi (passage #3 or later), which indicates the loss of the pSUmC-4.0 vector and incorporation of the loxP selection cassette into the genome.</li>
	<li>Choose one well of green-only inclusions to enrich by passaging. Harvest and freeze any other wells that also contain green-only inclusions in sucrose-phosphate-glutamate buffer (SPG).
	<ol>
		<li>To enrich green-only inclusions, passage the monolayer from one well of a 6 well plate as done in step 2.7, but after pelleting the cell debris (step 2.7.3), transfer the supernatant into a conical with 12 mL of HBSS. Use this inoculum to infect two 6 well plates by adding 2 mL per well, then spin the plates at 900 x g for 60 min at 20 &#176;C.</li>
		<li>To freeze additional wells, harvest the monolayer as in step 2.7.1, but resuspend the pellets in 1 mL of SPG instead of HBSS. Pellet the cell debris (step 2.7.3) and transfer the supernatant into a 1.5 mL cryotube. Freeze the material at -80 &#176;C.</li>
	</ol>
	</li>
	<li>After enriching green-only inclusions to a MOI of 0.5&#8211;1.0 (one to two more passages after detection), harvest the monolayers into SPG as described in step 2.11.2. Obtain aliquots of 50 &#181;L in 1.5 mL tubes and freeze at -80 &#176;C.</li>
	<li>Titer green-only bacteria to determine inclusion, forming units/&#181;L, according to a standard titration protocol17.</li>
</ol>
3. Clonal Isolation of Green-only C. trachomatis Deletion Mutant Containing the loxP Flanked Selection Cassette by Limiting Dilution
<ol>
	<li>Seed a 384 well tissue culture plate with 50 &#181;L of McCoy cells at ~2,000 cells/well in growth media #1. Incubate at 37 &#176;C with 5 % CO2 for ~24 h or until confluent.</li>
	<li>Dilute an aliquot of green-only bacteria in HBSS to achieve ~50 EBs per 20 mL. Transfer the diluted inoculum to a reservoir tray.
	<ol>
		<li>Remove the media from the 384 well plate by firmly flicking the entire plate upside down into a waste container. Using a multichannel pipette, add 50 &#181;L of C. trachomatis inoculum to each well. Infect by centrifugation at 900 x g for 1 h at 20 &#176;C. 
		NOTE: Be mindful not to flick so hard that the monolayer detaches. If cells are over-confluent, they will detach more easily.</li>
	</ol>
	</li>
	<li>Remove the inoculum by flicking and replace with 50 &#181;L/well growth media #2. Incubate plates at 37 &#176;C with 5% CO2. 
	NOTE: At this stage, integration of the selection cassette into the genome is stable, so antibiotic selection with spectinomycin is no longer required.</li>
	<li>After incubating the plate for 5&#8211;12 days, identify individual wells with green fluorescent inclusions using an epifluorescence inverted microscope or a high content screening platform.</li>
	<li>Harvest wells with green-only inclusions by scraping the monolayer with a p-10 tip and transferring the entire contents of the well into a tube containing 2 mL of HBSS. Gently mix and apply the 2 mL of inoculum to a fresh confluent McCoy monolayer in a 6 well plate for infection. 
	NOTE: When identifying individual wells with inclusions, the inclusions will be in a cluster due to expansion from the initial inclusion. If a well has multiple clusters, it is likely that more than one EB initially infected that well. These wells should not be harvested, and in some cases, multiple rounds of clonal isolation by serial dilution may be necessary.</li>
	<li>Infect the 6 well plate by centrifugation at 900 x g for 1 h at 20 &#176;C. Replace the inoculum with 2 mL/well growth media #2. Incubate at 37 &#176;C with 5 % CO2 for 48 h.</li>
	<li>Repeat steps 2.11&#8211;2.13 to enrich, freeze, and titer clonal populations.</li>
	<li>Confirm the deletion of targeted genes from clonally isolated C. trachomatis using qPCR as previously described12.</li>
</ol>
4. Transformation of C. trachomatis FRAEM Mutant with pSU-Cre to Initiate Removal of loxP Flanked Selection Cassette
<ol>
	<li>Repeat the transformation process in a 6 well plate as previously described (steps 2.1&#8211;2.8) using the clonally isolated C. trachomatis FRAEM mutant, pSU-Cre vector, and selection media #3. 
	NOTE: A successful transformation is indicated by inclusions that are red and green fluorescent.
	<ol>
		<li>Passage the monolayer until red-only inclusions are detected using an epifluorescence inverted microscope, which indicates loss of the selection cassette (two to three passages). Continue passaging the monolayer until red-only inclusions are enriched to a MOI of ~0.5.</li>
	</ol>
	</li>
	<li>Clonally isolate red-only inclusions by limiting dilution in a 384 well plate as previously described (steps 3.1&#8211;3.8); however, use selection media #3 for all steps.</li>
	<li>Enrich clonal populations by passaging until an MOI of 0.1. Once enriched, replace section media with growth media #2 to initiate loss of the pSU-Cre vector (approximately three to four passages).</li>
	<li>Clonally isolate nonfluorescent bacteria (steps 3.1&#8211;3.8); however, manually scan the plate with a brightfield microscope to detect inclusions. Enrich and freeze bacteria (step 2.11&#8211;2.12).</li>
	<li>Screen for the mutant strain using quantitative real-time PCR, Western blotting, and whole genome DNA Sequencing as previously described12.</li>
</ol>

<ol><li>World Health Organization. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Global+Incidence+and+Prevalence+of+Selected+Curable+Sexually+Transmitted+Infections%3A+2008%3A+World+Health+Organization%5BTitle%5D)+AND+%22Sexual+and+Reproductive+Health+Matters%22%5BJournal%5D)">Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections: 2008: World Health Organization.</a> Sexual and Reproductive Health Matters. 20, World Health Organization. World Health Organization, Department of Reproductive Health and Research, 2012 ISBN 978 92 4 1503839 207-208 (2012).</li>
<li>Stephen, R. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+Cellular+Paradigm+of+Chlamydial+Pathogenesis%5BTitle%5D)+AND+%22Trends+in+Microbiology%22%5BJournal%5D)">The Cellular Paradigm of Chlamydial Pathogenesis.</a> Trends in Microbiology. 11, 44-51 (2003).</li>
<li>Mueller, K. E., Plano, G. V., Fields, K. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((New+Frontiers+in+Type+III+Secretion+Biology%3A+the+Chlamydia+Perspective%5BTitle%5D)+AND+%22Infection+and+Immunity%22%5BJournal%5D)">New Frontiers in Type III Secretion Biology: the Chlamydia Perspective.</a> Infection and Immunity. 82, 2-9 (2014).</li>
<li>Seth-Smith, H. M. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Co-evolution+of+genomes+and+plasmids+within+Chlamydia+trachomatis+and+the+emergence+in+Sweden+of+a+new+variant+strain%5BTitle%5D)+AND+%22BMC+Genomics%22%5BJournal%5D)">Co-evolution of genomes and plasmids within Chlamydia trachomatis and the emergence in Sweden of a new variant strain.</a> BMC Genomics. 10, 239(2009).</li>
<li>Brothwell, J. A., Muramatsu, M. K., Zhong, G., Nelson, D. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Advances+and+obstacles+in+genetic+dissection+of+chlamydial+virulence%5BTitle%5D)+AND+%22Current+Topics+in+Microbiology+and+Immunology%22%5BJournal%5D)">Advances and obstacles in genetic dissection of chlamydial virulence.</a> Current Topics in Microbiology and Immunology. 412, 133-158 (2018).</li>
<li>McClure, E. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Engineering+of+obligate+Intracellular+bacteria%3A+progress%2C+challenges+and+paradigms%5BTitle%5D)+AND+%22Nature+Reviews+Microbiology%22%5BJournal%5D)">Engineering of obligate Intracellular bacteria: progress, challenges and paradigms.</a> Nature Reviews Microbiology. 15, 544-558 (2017).</li>
<li>Rahnama, M., Fields, K. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Transformation+of+Chlamydia%3A+current+approaches+and+impact+on+our+understanding+of+chlamydial+infection+biology%5BTitle%5D)+AND+%22Microbes+and+Infection%22%5BJournal%5D)">Transformation of Chlamydia: current approaches and impact on our understanding of chlamydial infection biology.</a> Microbes and Infection. 20 (7-8), 445-450 (2018).</li>
<li>Kari, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Generation+of+targeted+Chlamydia+trachomatis+null+mutants%5BTitle%5D)+AND+%22Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America%22%5BJournal%5D)">Generation of targeted Chlamydia trachomatis null mutants.</a> Proceedings of the National Academy of Sciences of the United States of America. 108, 7189-7193 (2011).</li>
<li>LaBrie, S. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Transposon+Mutagenesis+in+Chlmaydia+trachomatis+Identifies+CT339+as+a+ComEC+Homolog+Important+for+DNA+Uptake+and+Later+Gene+Transfer%5BTitle%5D)+AND+%22mBio%22%5BJournal%5D)">Transposon Mutagenesis in Chlmaydia trachomatis Identifies CT339 as a ComEC Homolog Important for DNA Uptake and Later Gene Transfer.</a> mBio. 10 (4), 01343(2019).</li>
<li>Johnson, C. M., Fisher, D. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Site-specific%2C+insertional+inactivation+of+incA+in+Chlamydia+trachomatis+using+a+group+II+intron%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Site-specific, insertional inactivation of incA in Chlamydia trachomatis using a group II intron.</a> PLoS One. 8, 83989(2013).</li>
<li>Mueller, K. E., Wolf, K., Fields, K. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Gene+Deletion+by+Fluorescence-Reported+Allelic+Exchange+Mutagenesis+in+Chlamydia+trachomatis%5BTitle%5D)+AND+%22mBio%22%5BJournal%5D)">Gene Deletion by Fluorescence-Reported Allelic Exchange Mutagenesis in Chlamydia trachomatis.</a> mBio. 7, 01817(2016).</li>
<li>Keb, G., Hayman, R., Fields, K. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Floxed+cassette+Allelic+Exchange+Mutagenesis+Enables+Markerless+Gene+Deletion+in+Chlamydia+trachomatis+and+can+Reverse+Cassette-Induced+Polar+Effects%5BTitle%5D)+AND+%22Journal+of+Bacteriology%22%5BJournal%5D)">Floxed cassette Allelic Exchange Mutagenesis Enables Markerless Gene Deletion in Chlamydia trachomatis and can Reverse Cassette-Induced Polar Effects.</a> Journal of Bacteriology. 200, 00479(2018).</li>
<li>Yarmolinsky, M., Hoess, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((THe+legacy+of+Nat+Sternberg%3A+the+genesis+of+Cre-lox+technology%5BTitle%5D)+AND+%22Annual+Review+of+Virology%22%5BJournal%5D)">THe legacy of Nat Sternberg: the genesis of Cre-lox technology.</a> Annual Review of Virology. 2, 25-40 (2015).</li>
<li>McKuen, M. J., Mueller, K. E., Bae, Y. S., Fields, K. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fluorescence-Reported+Allelic+Exchange+Mutagenesis+Reveals+a+Role+for+Chlamydia+trachomatis+TmeA+in+Invasion+that+is+Independent+of+Host+AHNAK%5BTitle%5D)+AND+%22Infection+and+Immunity%22%5BJournal%5D)">Fluorescence-Reported Allelic Exchange Mutagenesis Reveals a Role for Chlamydia trachomatis TmeA in Invasion that is Independent of Host AHNAK.</a> Infection and Immunity. 85 (12), 00640(2017).</li>
<li>Song, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Chlamydia+trachomatis+Plasmid-Encoded+Pgp4+is+a+Transcriptional+Regulator+of+Virulence-Associated+Genes%5BTitle%5D)+AND+%22Infection+and+Immunity%22%5BJournal%5D)">Chlamydia trachomatis Plasmid-Encoded Pgp4 is a Transcriptional Regulator of Virulence-Associated Genes.</a> Infection and Immunity. 81 (3), 636-644 (2013).</li>
<li>Silayeva, O., Barnes, A. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Gibson+Assembly+facilitates+bacterial+allelic+exchange+mutagenesis%5BTitle%5D)+AND+%22Journal+of+Microbiological+Methods%22%5BJournal%5D)">Gibson Assembly facilitates bacterial allelic exchange mutagenesis.</a> Journal of Microbiological Methods. 144, 157-163 (2017).</li>
<li>Hackstadt, T., Scidmore, M., Rockey, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Lipid+Metabolism+in+Chlamydia+trachomatis-Infected+Cells%3A+Directed+Trafficking+of+Golgi-Derived+Sphingolipids+to+the+Chlamydial+Inclusion%5BTitle%5D)+AND+%22Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America%22%5BJournal%5D)">Lipid Metabolism in Chlamydia trachomatis-Infected Cells: Directed Trafficking of Golgi-Derived Sphingolipids to the Chlamydial Inclusion.</a> Proceedings of the National Academy of Sciences of the United States of America. 92 (11), 4877-4881 (1995).</li>
<li>Jeffrey, B. M., Suchland, R. J., Eriksen, S. G., Sandoz, K. M., Rockey, D. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Genomic+and+phenotypic+characterization+of+in+vitro-generated+Chlamydia+trachomatis+recombinants%5BTitle%5D)+AND+%22BMC+Microbiology%22%5BJournal%5D)">Genomic and phenotypic characterization of in vitro-generated Chlamydia trachomatis recombinants.</a> BMC Microbiology. 13, 142(2013).</li>
<li>Suchland, R. J., Bourillon, A., Denamur, E., Stamm, W. E., Rothstein, D. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Rifampin-resistant+RNA+polymerase+mutants+of+Chlamydia+trachomatis+remain+susceptible+to+the+ansamycin+rifalazil%5BTitle%5D)+AND+%22Antimicrobial+Agents+Chemotherapy%22%5BJournal%5D)">Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil.</a> Antimicrobial Agents Chemotherapy. 49, 1120-1126 (2005).</li>
</ol>

The authors have no conflicts of interest to disclose.

The protocol described here for the generation of markerless gene deletions in C. trachomatis by FLAEM allows targeted deletion of nonessential genes and eliminates cassette-induced polar effects. The protocol relies upon careful design of 5&#39; and 3&#39; homology arms inserted into the pSUmC 4.0 suicide vector, efficient transformation of C. trachomatis, and careful screening of isolated mutant strains. Successful genome engineering via this method results in bacteria that are nonfluorescent and cont...

Chlamydia trachomatis is the leading cause of bacterial sexually transmitted disease and represents a significant burden to human health. Over 100 million people are infected every year with C. trachomatis1. Approximately 70% of the infections in women are asymptomatic despite detrimental reproductive health effects, such as pelvic inflammatory disease, ectopic pregnancy, and/or infertility. Disease sequela are directly related to immunopathology initiated by C. trachomatis infection2. An efficacious vaccine has yet to be developed; therefore, understanding the function of bacterial virulence factors and other bacterial gene products is an important and urgent research question.
As intracellular bacteria, host cell invasion, intracellular replication, release of progeny, and evasion of host immunological responses are critical processes. C. trachomatis forms a parasitophorous membrane bound vacuole, termed an inclusion, for intracellular development. Establishment of the inclusion and many other critical processes are achieved by secretion of effector proteins via a type III secretion system (T3SS)3. Elucidating the functions of these secreted effectors was limited for many years due to the genetic intractability of C. trachomatis. Unlike E. coli, many classical cloning techniques are not applicable to Chlamydia. A few major limitations involve transformation efficiency, lack of counterselection reporters such as sacB, and plasmid maintenance. Whereas E. coli plasmids can generally be maintained indefinitely with an origin of replication and appropriate selective pressure, C. trachomatis plasmids requires an additional eight open reading frames (pgp1-8) for maintenance that are found on the native pL2 plasmid within the L2 serovar4.
In recent years there have been multiple genetic tools generated that accommodate Chlamydia&#39;s unique biology, yet there are still limitations5,6,7. Chemical mutagenesis by ethyl methanesulfonate (EMS) treatment can introduce missense mutations, or (less frequently) can result in nucleotide transitions introducing a premature stop codon to yield a nonsense mutation8. Transposon insertion is efficient for gene disruption, but current technology in Chlamydia research is laborious and time-consuming9. Both EMS treatment and transposon mutagenesis techniques generate random mutations and require rigorous screening methods to isolate mutant strains. A method to disrupt genes by insertion of group II introns (e.g., TargeTron) allows for directed mutagenesis; however, this method is limited by efficiency, and the insertion site is not always properly predicted10.
Fluorescence-reported allelic exchange mutagenesis (FRAEM) is a strategy used for targeted gene deletion coupled with insertion of a selection cassette providing antibiotic resistance and a fluorescence reporter11. Yet, FRAEM is complicated by the potential of cassette-induced polar effects on downstream genes, especially when targeting genes within polycistronic operons. Floxed cassette allelic exchange mutagenesis (FLAEM) is a novel genetic approach developed to alleviate the cassette-induced polar effects previously observed with the FRAEM selection cassette12. FLAEM utilizes Cre-loxP genome editing to remove the selection cassette and restore expression of downstream genes. The selection cassette containing antibiotic resistance and green fluorescent protein (GFP) is reengineered with flanking loxP sites. These loxP sites can recombine in the presence of Cre recombinase and result in excision of the cassette from the genome13. This strategy has been shown to alleviate cassette induced polar effects when targeting tmeA for deletion12,14.
Both FRAEM and FLAEM methods utilize the same suicide vector, pSUmC 4.0, which can be conditionally maintained through inducible expression of pgp6. Expression of pgp6 has previously been shown to be necessary for plasmid retention and is therefore leveraged to control plasmid maintenance11,15. When C. trachomatis is grown in media supplemented with anhydrous tetracycline (aTc) to induce pgp6 expression, the vector is maintained. In the absence of aTc, the vector is lost. Targeted gene deletion is achieved through allelic exchange of the gene for the selection cassette. The 3 kb regions directly upstream and downstream of the targeted gene serve as homology arms for recombination. These arms are cloned into the pSUmC 4.0 vector flanking the selection cassette. Successful C. trachomatis transformation and recombination events are observed through fluorescence reporting. Expression of mCherry on the vector backbone and gfp within the selection cassette yield red and green fluorescent inclusions. Once aTc is removed from culture media, green-only inclusions indicate successful recombination events with the loss of the suicide vector and integration of the selection cassette into the bacterial genome.
FLAEM represents an extension of FRAEM via subsequent transformation of a Cre recombinase-expressing vector, pSU-Cre, into the newly created mutant strain. Cre recombinase facilitates recombination between loxP sites and excision of the selection cassette. Recombination events are indicated via fluorescence reporting. The pSU-Cre vector encodes mCherry; thus, successful transformation is indicated by addition of red fluorescence to gfp-expressing inclusions. Cultivation in the absence of selective pressure for the cassette results in Cre-mediated recombination at the loxP sites, and loss of the cassette is indicated by red-only inclusions. As with pSUmC-4.0, inducible expression of pgp6 is used to conditionally maintain pSU-Cre. Once aTc and antibiotic selection are removed, the plasmid is cured, and the resulting markerless deletion strain is nonfluorescent. This method addresses the issue of cassette-induced polar effects.

<table><tbody><tr><td>Agarose</td><td>KSE Scientific</td><td>BMK-A1705</td><td>Molecular Biology Grade</td></tr><tr><td>Anhydrotetracycline hydrochloride</td><td>ACROS Organics</td><td>233131000</td><td></td></tr><tr><td>CaCl&lt;sub&gt;2&lt;/sub&gt; Buffer</td><td></td><td></td><td>10 mM Tris pH 7.4, 50 mM Calcium Chloride Dihydrate</td></tr><tr><td>Calcium Chloride Dihydrate</td><td>Sigma</td><td>C7902-500G</td><td>Suitable for cell culture</td></tr><tr><td>Cycloheximide</td><td>Sigma</td><td>7698-1G</td><td></td></tr><tr><td>dam&lt;sup&gt;-&lt;/sup&gt;/dcm&lt;sup&gt;-&lt;/sup&gt; Competent &lt;em&gt;E. coli&lt;/em&gt;</td><td>New England BioLabs</td><td>C2925H</td><td></td></tr><tr><td>DMSO</td><td>ATCC</td><td>4-X</td><td>Sterile filtered cell culture tested</td></tr><tr><td>Glutamic acid</td><td>Sigma</td><td>G8415-100G</td><td>L-Glutamic acid</td></tr><tr><td>Growth Media #1</td><td></td><td></td><td>RPMI 1640 media supplemented with 10 % (vol/vol) heat-inactivated fetal bovine serum (FBS).</td></tr><tr><td>Growth Media #2</td><td></td><td></td><td>RPMI 1640 media supplemented with 10 % (vol/vol) heat-inactivated fetal bovine serum (FBS) and 1 &amp;micro;g/mL cycloheximide</td></tr><tr><td>Hanks&#039; Balanced Salt Solution (HBSS) (1x)</td><td>Gibco</td><td>24020-117</td><td></td></tr><tr><td>Heat Inactivated Fetal Bovine Serum Qualified One Shot (FBS)</td><td>Gibco</td><td>A38402-02</td><td></td></tr><tr><td>McCoy Cells</td><td>ATCC</td><td>CRL-1696</td><td></td></tr><tr><td>Monarch Plasmid Miniprep Kit</td><td>New England BioLabs</td><td>T1010S</td><td>Small scale DNA purification</td></tr><tr><td>NaH&lt;sub&gt;2&lt;/sub&gt;PO&lt;sub&gt;4&lt;/sub&gt;</td><td>Sigma</td><td>S3139-250G</td><td>Sodium phosphate monobasic</td></tr><tr><td>Na&lt;sub&gt;2&lt;/sub&gt;HPO&lt;sub&gt;4&lt;/sub&gt;</td><td>Sigma</td><td>S5136-500G</td><td>Sodium phosphate dibasic</td></tr><tr><td>NEB 10-beta Electrocompetent &lt;em&gt;E. coli&lt;/em&gt; Cells</td><td>New England BioLabs</td><td>C3020K</td><td></td></tr><tr><td>NEBuilder HiFi DNA assembly Cloning Kit</td><td>New England BioLabs</td><td>E5520S</td><td>Gibson Assembly Kit</td></tr><tr><td>Penicillin G sodium salt</td><td>Sigma</td><td>P3032-10MU</td><td>Bioreagent suitable for cell culture</td></tr><tr><td>QIAGEN Plasmid Maxi Kit</td><td>QIAGEN</td><td>12162</td><td>Large scale DNA purification</td></tr><tr><td>Q5 Hot Start High-Fidelity DNA Polymerase</td><td>New England BioLabs</td><td>M0515</td><td>Fragment PCR Polymerase</td></tr><tr><td>RPMI 1640 Medium (1x)</td><td>Gibco</td><td>11875-093</td><td>Containing 2mM L-glutamine</td></tr><tr><td>Sall-HF</td><td>New England BioLabs</td><td>R3138S</td><td></td></tr><tr><td>Sbfl-HF</td><td>New England BioLabs</td><td>R3642S</td><td></td></tr><tr><td>Selection Media #1</td><td></td><td></td><td>RMPI 10 % FBS, 1 &amp;micro;g/mL cycloheximide, 500 &amp;micro;g/mL spectinomycin, and 50 ng/mL anhydrous tetracycline dissolved in DMSO</td></tr><tr><td>Selection Media #2</td><td></td><td></td><td>RMPI 10 % FBS, 1 &amp;micro;g/mL cycloheximide, 500 &amp;micro;g/mL spectinomycin</td></tr><tr><td>Selection Media #3</td><td></td><td></td><td>RPMI 10 % FBS, 1 &amp;micro;g/mL cycloheximide, 50 ng/mL aTc, and 0.6 &amp;micro;g/mL penicillin</td></tr><tr><td>Sodium Acetate Buffer Solution</td><td>Sigma</td><td>S7899-100ML</td><td>3M</td></tr><tr><td>SOC Outgrowth Medium</td><td>New England BioLabs</td><td>B9020SVIAL</td><td></td></tr><tr><td>Spectinomycin dihydrochloride pentahydrate, Cell Culture Grade</td><td>Alfa Aesar</td><td>J61820</td><td></td></tr><tr><td>Sucrose</td><td>Sigma</td><td>S1888-1KG</td><td>Bioreagent suitable for cell culture</td></tr><tr><td>Sucrose-Phosphate-Glutamate Buffer (SPG)</td><td></td><td></td><td>37.5g sucrose, 1.25 g Na&lt;sub&gt;2&lt;/sub&gt;HPO&lt;sub&gt;4&lt;/sub&gt;, 0.18 g NaH&lt;sub&gt;2&lt;/sub&gt;PO&lt;sub&gt;4&lt;/sub&gt;, 0.36 glutamic acid for 500 ml tissue culture grade water</td></tr><tr><td>Tris</td><td>AMRESCO</td><td>0497-5KG</td><td>Ultrapure grade</td></tr><tr><td>Trypsin-EDTA (1x)</td><td>Gibco</td><td>25200-056</td><td>0.25%</td></tr><tr><td>Water</td><td>Sigma</td><td>W3500-500ML</td><td>Sterile-filtered, BioReagent, Suitable for cell culture</td></tr></tbody></table>

markerless gene deletion by floxed cassette allelic exchange mutagenesis in chlamydia trachomatis

Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis

Chlamydia trachomatis is an obligate intracellular pathogen that has been historically difficult to genetically manipulate. Definitive progress in elucidating the mechanisms that C. trachomatis use to create and maintain a privileged intracellular niche has been limited due to a lack of genetic tools. Fortunately, there have recently been several new advances in genetic manipulation techniques. Among these is the development of fluorescence-reported allelic exchange mutagenesis (FRAEM). This method allows targeted gene deletion coupled with insertion of a selection cassette encoding antibiotic resistance and green fluorescent protein (GFP). Reliance on this strategy can be complicated when targeting genes within polycistronic operons due to the potential of polar effects on downstream genes. Floxed cassette allelic exchange mutagenesis (FLAEM), the protocol for which is described here, was developed to alleviate cassette-induced polar effects. FLAEM utilizes Cre-loxP genome editing to remove the selection cassette after targeted deletion by allelic exchange. The resulting strains contain markerless gene deletions of one or more coding sequences. This technique facilitates direct assessment of gene function and expands the repertoire of tools for genetic manipulation in C. trachomatis.

The method for markerless gene deletion in C. trachomatis using FLAEM is reliant upon careful cloning and transformation techniques. Successful allelic recombination is an essential first step and requires the identification and insertion of homology arms into the pSUmC-4.0 cloning vector (Figure 1). An essential second step for markerless gene deletion is removal of the fluorescence reporter and antibiotic selection cassette by Cre-lox genome editing, represented in <strong class="...

Described here is a method for targeted, markerless gene deletion in Chlamydia trachomatis using floxed cassette allelic exchange mutagenesis, FLAEM.

Chlamydia trachomatis is an obligate intracellular pathogen that has been historically difficult to genetically manipulate. Definitive progress in ...

markerless-gene-deletion-floxed-cassette-allelic-exchange-mutagenesis

Research

JoVE Journal

Immunology and Infection

A quick and efficient method to integrate foreign DNA of interest into pre-made acceptor strains, termed landing pad strains, is described. The method allows site-specific integration of a DNA cassette into the engineered landing pad locus of a given strain, through conjugation and expression of the ΦC31 integrase.

Site-specific Bacterial Chromosome Engineering: &#934;C31 Integrase Mediated Cassette Exchange (IMCE)

Systematic, large-scale synthetic genetic (gene-gene or epistasis) interaction screens can be used to explore genetic redundancy and pathway cross-talk. Here, we describe a high-throughput quantitative synthetic genetic array screening technology, termed eSGA that we developed for elucidating epistatic relationships and exploring genetic interaction networks in Escherichia coli.

Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays

Source: Saragliadis, A., et al. Producing Gene Deletions in Escherichia coli by P1 Transduction with Excisable Antibiotic Resistance Cassettes. J. Vis. Exp. (2018)This video demonstrates the phage-mediated transfer of donor DNA carrying an excisable antibiotic resistance cassette into Escherichia coli. The integrated cassette replaces the target gene via homologous recombination, resulting in a stable gene deletion.

Generating Gene Deletions in E. coli via Phage-Mediated Transfer of an Excisable Antibiotic Cassette

We describe a methodology to perform genetic analysis in Chlamydia based on chemical mutagenesis and whole genome sequencing. In addition, a system for DNA exchange within infected cells is described that can be used for genetic mapping. This method may be broadly applicable to microbial systems lacking transformation systems and molecular genetic tools.

Forward Genetic Approaches in Chlamydia trachomatis

Here, we present a method to engineer the genome of C. elegans using CRISPR-Cas9 ribonucleoproteins and homology dependent repair templates.

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

Here we present a protocol for the use of pre-existing antibiotic resistance-cassette deletion constructs as a basis for making deletion mutants in other E. coli strains. Such deletion mutations can be mobilized and inserted into the corresponding locus of a recipient strain using P1 bacteriophage transduction.

Producing Gene Deletions in Escherichia coli by P1 Transduction with Excisable Antibiotic Resistance Cassettes

Bacterial pathogens secrete proteins into the host that target crucial biological processes. Identifying the host pathways targeted by bacterial effector proteins is key to addressing molecular pathogenesis. Here, a method using a modified yeast suppressor and toxicity screen to elucidate host pathways targeted by toxic bacterial effector proteins is described.

Identification of Host Pathways Targeted by Bacterial Effector Proteins using Yeast Toxicity and Suppressor Screens

This protocol utilizes fluorescent promoter-reporters, live-cell microscopy, and individual inclusion extraction in a directed forward genetic approach to identify and isolate developmental mutants of Chlamydia trachomatis.

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Here, we describe the construction of null mutants of Aeromonas in specific glycosyltransferases or regions containing glycosyltransferases, the motility assays, and flagella purification performed to establish the involvement and function of their encoded enzymes in the biosynthesis of a glycan, as well as the role of this glycan in bacterial pathogenesis.

Generation of Null Mutants to Elucidate the Role of Bacterial Glycosyltransferases in Bacterial Motility

Oligonucleotides can be used to site specifically substitute a single nucleotide of transfected target genes in both Anopheles gambiae and Anopheles stephensi cells.

Transfection and Mutagenesis of Target Genes in Mosquito Cells by Locked Nucleic Acid-modified Oligonucleotides

Learn markerless gene deletion in Chlamydia trachomatis using floxed cassette allelic exchange mutagenesis. This precise method enables targeted genetic manipulation without polar effects on downstream genes.

Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis

Explore More Videos